Loading
Latest filing published 16 Dec 2025 for Sensus Healthcare, Inc..
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Michael Sardano is a declared insider of Sensus Healthcare, Inc. (board member), with filings sourced from SEC (Form 4). Over a trading history stretching from 2 June 2018 to 12 December 2025, the count stands at 26 filings.
In open-market terms, that means 13 purchases worth €39k on one side and 1 sale worth €71k on the other. Netting one side against the other leaves €31k of net selling. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 11 share grants and 1 option exercise. 2025 to date brings 10 purchases and no sales.
The median purchase comes to €2,877. Clusters matter here: 5 out of 10 purchases overlapped with buying by a colleague within 30 days. Purchases made close together by different insiders form what is called a cluster.
The latest filing, published on 16 December 2025, reports a share grant in Sensus Healthcare, Inc. The last insider purchase was made public on 19 November 2025, 339 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
17 of 17 declarations